Sinofn Health
As the global health and wellness sector pivots toward hyper-personalization, SINOFN Health emerges as a vanguard of the ODM (Original Design Manufacturer) movement. The industry is witnessing a shift where traditional manufacturing is being replaced by science-led nutraceutical development.
The nutraceutical market is transcending basic vitamin production. Current macro-trends identify three pillars: Bioavailability, Clean Label Sourcing, and Functional Complexity. SINOFN leverages its partnership with the Chinese Academy of Sciences (CAS) to stay ahead of these trends, transforming laboratory breakthroughs into scalable industrial products.
Founded in 2012 by Mrs. GuoHong Liu, SINOFN was born out of a necessity to democratize clinical-grade nutrition—specifically for PKU (Phenylketonuria) patients. This "Profit with Purpose" philosophy forms our E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) cornerstone. We aren't just a factory; we are a translational medical science entity.
Our R&D team is led by Dr. Tan Shengjie and Dr. Zhang Ying, bridging the gap between metabolic disorder research and everyday health supplements. Our technology roadmap includes:
10+ dedicated lines for softgels, gummies, and complex powders. ISO 22000 & FSSC 22000 certified.
Rigorous HPLC/GC-MS screening for contaminants. Full microbiological safety validation.
Pilot-scale development for tablets/liquids. Bioavailability optimization studies.
BRCGS-certified warehousing with blockchain-backed batch traceability.
OEM (Original Equipment Manufacturing) involves manufacturing to a client's design, whereas ODM (Original Design Manufacturing)—our specialty—involves providing the R&D, formulation expertise, and scientific backing, allowing brands to launch superior products faster.
Our quality management systems are aligned with international standards including ISO and HACCP. We possess significant expertise in EU, US, and Asian market regulations, ensuring our supplements meet local health authority requirements.
Yes. Our R&D center is specifically designed for pilot runs. This allows startups and enterprises to test market reception before scaling to full industrial production.